Blog / Archives
Biotechs Cruise onto Green Screen: July Looks Good…Updates
Updates: 7/19 pm... Abbvie (ABBV) takes a 4.7% hit on Citron short seller call. Basis for call would be pressure from FDA and Scott Gottlieb concerning stalling by drug companies on biosimilars....
Biotech Rally Buffeted By Trump Tweet But Gains Hold…Update-2
Update-2 ...Futures Sink As Trade War Rhetoric Heats Up: China Responds to Trump Additional $200B in tariffs on Chinese goods that may get hit with tariffs-See Bloomberg updates. China will take...
Biotech Momentum Is Boosted by Biogen’s Alzheimer Disease Drug Results
Biotech Momentum Boosted by Biogen's Experimental Drug Biogen Has an Interesting Pipeline of Medicines for Serious Neurological Diseases Broad Biotech Rally-Green Screen Day- Even Large Caps...
Biotech Bull Market: ETFs and Life Science Mutual Funds 2018 YTD
Biotech Bull Market: Up 25.39% Over 2 Years With High Volatility XBI Outperforms Up 12% YTD; FBT is Comparable, IBB lags. Three Funds did well in H1 2018 (7-9%). Biotech stocks peaked in July 2015...
Rayno BioBeat #4 2018: ASCO Biotech Momentum Continues with M&A Theme…Updates 6/29
Momentous Biotech for June Update 6/28...A nice broad rally on Friday included the large cap biotechs with the IBB up 1.73% to $109.82. Even Celgene (CELG) found buyers up 3.6% flirting with the...
Rayno Life Science Portfolio Flash Update: Roche and FMI Merger; Update with XBI breakout
Rayno Life Science Portfolio FMI: Personalized Medicine for Oncology We are on vacation this week but need to update you on Roche (RHHBY) complete buyout of Foundation Medicine (FMI) one of our top...
Mid-Cap Biotech Watch List: Updated 6/12/18 After Huge ASCO Rally
Updated 6/18 pre-market Biotech Update for Week Ending 6/15 A relatively quiet less volatile week with the bullish trend intact at "triple-top" with XBI at $97 level. However, NASDAQ weakness...
Biotech Mid-Cap Momentum Leaders and Laggards…Update…gene editing
Update-1 Gene Editing stocks are hit hard by a STAT Report that edited cells may cause cancer. Here is a later summary from STAT. As of 2:45 PDT trading; CRSP down 12% at $60, EDIT down 7.8% at...
ASCO 2018 Biotech Rally Part 2 : Traders Take Profits on Nice Gains…Updates
ASCO 2018 Rally Part 2: Traders Take Profits on Nice Gains Biotech Indices and ETFs Show Gains YTD: FBIOX up 8% YTD, IBB up 3.13%, XBI up 9.34% The ASCO 2018 biotech rally was almost according to...
ASCO 2018 Biotech Rally : Teetering at the Top But a Leading Sector
ASCO 2018 Biotech Rally: Biotechs, Techs, and Semis Lead Market Higher Mid-Caps show huge gains but with high volatility. FBT at 142.91, IBB lagging at $110.52, XBI leading at $97.77 IWC Micro-Cap...